The use of esketamine in the treatment of patients with oral antidepressant-resistant depression: systematic review and meta-analysis

Carregando...
Imagem de Miniatura
Citações na Scopus
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC MEDICA BRASILEIRA
Autores
FLORIANO, Idevaldo
SILVINATO, Antonio
Citação
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.69, n.6, article ID e2023D696, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct, and to assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient. Guideline conclusion: April 2023. Societies: Brazilian Medical Association.
Palavras-chave
Referências
  1. Agboola F, 2020, J MANAG CARE SPEC PH, V26, P16, DOI 10.18553/jmcp.2020.26.1.16
  2. [Anonymous], 2020, REV MANAGER REVMAN C
  3. Bahji A, 2021, J AFFECT DISORDERS, V278, P542, DOI 10.1016/j.jad.2020.09.071
  4. Correia-Melo FS, 2020, J AFFECT DISORDERS, V264, P527, DOI 10.1016/j.jad.2019.11.086
  5. Daly EJ, 2019, JAMA PSYCHIAT, V76, P893, DOI 10.1001/jamapsychiatry.2019.1189
  6. Daly EJ, 2018, JAMA PSYCHIAT, V75, P139, DOI 10.1001/jamapsychiatry.2017.3739
  7. Diekamp B, 2021, NEUROPSYCH DIS TREAT, V17, P2347, DOI 10.2147/NDT.S314874
  8. Evidence Prime Inc, 2020, GRADEPRO GDT GRADEPR
  9. Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2
  10. Fedgchin M, 2019, INT J NEUROPSYCHOPH, V22, P616, DOI 10.1093/ijnp/pyz039
  11. Grade Working Group, US
  12. Jones RR, 2022, ARCH WOMEN MENT HLTH, V25, P313, DOI 10.1007/s00737-021-01185-6
  13. Katz EG, 2021, CLIN PHARMACOL THER, V109, P536, DOI 10.1002/cpt.2024
  14. Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3
  15. MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
  16. Ng J, 2021, J AFFECT DISORDERS, V293, P285, DOI 10.1016/j.jad.2021.06.032
  17. Nijs M, 2020, INT J NEUROPSYCHOPH, V23, P426, DOI 10.1093/ijnp/pyaa027
  18. Ochs-Ross R, 2020, AM J GERIAT PSYCHIAT, V28, P121, DOI 10.1016/j.jagp.2019.10.008
  19. Page MJ, 2021, INT J SURG, V88, DOI [10.1016/j.ijsu.2021.105906, 10.1186/s13643-021-01626-4, 10.1016/j.rec.2021.07.010, 10.1016/j.recesp.2021.06.016, 10.1016/j.jclinepi.2021.03.001, 10.1136/bmj.n71]
  20. Papakostas GI, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.19r12889
  21. Popova V, 2019, AM J PSYCHIAT, V176, P428, DOI 10.1176/appi.ajp.2019.19020172
  22. Singh JB, 2016, BIOL PSYCHIAT, V80, P424, DOI 10.1016/j.biopsych.2015.10.018
  23. Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002
  24. Smith-Apeldoorn SY, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2359-1
  25. Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898
  26. Takahashi N, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03538-y
  27. Targum SD, 2019, J PSYCHIATR RES, V111, P68, DOI 10.1016/j.jpsychires.2019.01.017
  28. Turkoz I, 2021, J CLIN PSYCHIAT, V82, DOI 10.4088/JCP.20m13800
  29. Vazquez GH, 2021, J PSYCHOPHARMACOL, V35, P890, DOI 10.1177/02698811211013579
  30. Wajs E, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.19m12891
  31. Wei Y, 2022, MOL PSYCHIATR, V27, P559, DOI 10.1038/s41380-021-01121-1